• GemVax & KAEL corrected its disclosure on October 19, 2026, reducing total borrowings to KRW 44.77 billion from KRW 44.86 billion.
• The correction reflects partial repayment of Gem & Company's Hana Bank loan, with collateral extended through April 19, 2027.
• Full enforcement of the share pledges would reduce the largest shareholder's stake from 11.95% to 0.01%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GemVax & KAEL Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261019900433), on October 19, 2026, and is solely responsible for the information contained therein.